CONTACT GSK 1-877-512-1344
According to GOLD 2018, use of multiple inhalers is one factor that may lead to poor inhaler technique.2
TRELEGY does not replace a rescue inhaler. Patients should be provided a short-acting beta2-agonist, such as albuterol, to treat acute symptoms and instructed on how it should be used.
Dosing considerations for TRELEGY:
Instruct patients to rinse their mouths with water after inhalation to reduce the risk of oropharyngeal candidiasis.
|Strip 1 contains fluticasone furoate (100 mcg per blister)|
|Strip 2 contains a blend of umeclidinium (62.5 mcg per blister) and vilanterol (25 mcg per blister)|
For more information, see the
Instructions for Use in the Patient
Information Leaflet for TRELEGY.
Stay up-to-date with new information on